52 related articles for article (PubMed ID: 16263120)
1. Regulation of EGF receptor signaling by the MARVEL domain-containing protein CKLFSF8.
Jin C; Ding P; Wang Y; Ma D
FEBS Lett; 2005 Nov; 579(28):6375-82. PubMed ID: 16263120
[TBL] [Abstract][Full Text] [Related]
2. CMTM6: A Critical Prognostic Indicator in Non-Small Cell Lung Cancer.
Dai F; Duan YL; Feng Q; Song SL; Yang JL; Lv T
J Cancer; 2024; 15(8):2373-2379. PubMed ID: 38495487
[TBL] [Abstract][Full Text] [Related]
3. Research advances of MAL family members in tumorigenesis and tumor progression (Review).
Li M; Du Y; Zhang X; Zhou W
Mol Med Rep; 2024 Apr; 29(4):. PubMed ID: 38362940
[TBL] [Abstract][Full Text] [Related]
4. The origin, evolution, and molecular diversity of the chemokine system.
Aleotti A; Goulty M; Lewis C; Giorgini F; Feuda R
Life Sci Alliance; 2024 Mar; 7(3):. PubMed ID: 38228369
[TBL] [Abstract][Full Text] [Related]
5. The MAL Family of Proteins: Normal Function, Expression in Cancer, and Potential Use as Cancer Biomarkers.
Labat-de-Hoz L; Rubio-Ramos A; Correas I; Alonso MA
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345137
[TBL] [Abstract][Full Text] [Related]
6. Suppression of Tumor or Host Intrinsic CMTM6 Drives Antitumor Cytotoxicity in a PD-L1-Independent Manner.
Long Y; Chen R; Yu X; Tong Y; Peng X; Li F; Hu C; Sun J; Gong L
Cancer Immunol Res; 2023 Feb; 11(2):241-260. PubMed ID: 36484740
[TBL] [Abstract][Full Text] [Related]
7. Construction of stable membranal CMTM6-PD-L1 full-length complex to evaluate the PD-1/PD-L1-CMTM6 interaction and develop anti-tumor anti-CMTM6 nanobody.
Jia XM; Long YR; Yu XL; Chen RQ; Gong LK; Geng Y
Acta Pharmacol Sin; 2023 May; 44(5):1095-1104. PubMed ID: 36418428
[TBL] [Abstract][Full Text] [Related]
8. CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment.
Zhang T; Yu H; Dai X; Zhang X
Front Immunol; 2022; 13():971428. PubMed ID: 35958549
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-582-5p promotes triple-negative breast cancer invasion and metastasis by antagonizing CMTM8.
Zeng X; Ma X; Guo H; Wei L; Zhang Y; Sun C; Han N; Sun S; Zhang N
Bioengineered; 2021 Dec; 12(2):10126-10135. PubMed ID: 34978519
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of the prognostic value of the chemokine-like factor-like MARVEL transmembrane domain-containing family in gastric cancer.
Liang Z; Xie J; Huang L; Huang Y; Zhang Y; Ma R; Zheng Z; Wang Q; Li X
J Gastrointest Oncol; 2021 Apr; 12(2):388-406. PubMed ID: 34012634
[TBL] [Abstract][Full Text] [Related]
11. Chemokine-Like Factor-Like MARVEL Transmembrane Domain-Containing Family in Hepatocellular Carcinoma: Latest Advances.
Li M; Luo F; Tian X; Yin S; Zhou L; Zheng S
Front Oncol; 2020; 10():595973. PubMed ID: 33282744
[TBL] [Abstract][Full Text] [Related]
12. CMTM family proteins 1-8: roles in cancer biological processes and potential clinical value.
Wu J; Li L; Wu S; Xu B
Cancer Biol Med; 2020 Aug; 17(3):528-542. PubMed ID: 32944388
[TBL] [Abstract][Full Text] [Related]
13. CMTM5-v1 inhibits cell proliferation and migration by downregulating oncogenic EGFR signaling in prostate cancer cells.
Yuan Y; Sheng Z; Liu Z; Zhang X; Xiao Y; Xie J; Zhang Y; Xu T
J Cancer; 2020; 11(13):3762-3770. PubMed ID: 32328181
[TBL] [Abstract][Full Text] [Related]
14. Research Advances in CKLF-like MARVEL Transmembrane Domain-containing Family in Non-small Cell Lung Cancer.
Wu K; Li X; Gu H; Yang Q; Liu Y; Wang L
Int J Biol Sci; 2019; 15(12):2576-2583. PubMed ID: 31754330
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-Specific Protease 8 Mutant Corticotrope Adenomas Present Unique Secretory and Molecular Features and Shed Light on the Role of Ubiquitylation on ACTH Processing.
Sesta A; Cassarino MF; Terreni M; Ambrogio AG; Libera L; Bardelli D; Lasio G; Losa M; Pecori Giraldi F
Neuroendocrinology; 2020; 110(1-2):119-129. PubMed ID: 31280266
[TBL] [Abstract][Full Text] [Related]
16. On The Role of Myelin and Lymphocyte Protein (MAL) In Cancer: A Puzzle With Two Faces.
Lara-Lemus R
J Cancer; 2019; 10(10):2312-2318. PubMed ID: 31258734
[TBL] [Abstract][Full Text] [Related]
17. CMTM4 regulates angiogenesis by promoting cell surface recycling of VE-cadherin to endothelial adherens junctions.
Chrifi I; Louzao-Martinez L; Brandt MM; van Dijk CGM; Bürgisser PE; Zhu C; Kros JM; Verhaar MC; Duncker DJ; Cheng C
Angiogenesis; 2019 Feb; 22(1):75-93. PubMed ID: 30097810
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of the tumor suppressor CMTM8 and its association with prognosis in bladder cancer.
Zhang S; Pei X; Hu H; Zhang W; Mo X; Song Q; Zhang Y; Xu K; Wang Y; Na Y
Tumour Biol; 2016 May; 37(5):6217-25. PubMed ID: 26615421
[TBL] [Abstract][Full Text] [Related]
19. CMTM8 inhibits the carcinogenesis and progression of bladder cancer.
Gao D; Hu H; Wang Y; Yu W; Zhou J; Wang X; Wang W; Zhou C; Xu K
Oncol Rep; 2015 Dec; 34(6):2853-63. PubMed ID: 26503336
[TBL] [Abstract][Full Text] [Related]
20. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
